White label ELPA - ClinicalTrials.eu

Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Oxygen Ph.eur.
Study on the Effects of ISIS 678354 in Patients with Familial Chylomicronemia Syndrome (FCS)

Not recruiting

3 1 1
Investigated Diseases:
- Familial hypertriglyceridaemia
- Hyperchylomicronaemia
Investigated Drugs:
- Isis 678354 Sodium Salt
+1
Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Head and neck cancer metastatic
Investigated Drugs:
- Eftilagimod Alfa
- Pembrolizumab
Study on Zoledronic Acid for Treating Osteosarcoma in Children, Adolescents, and Adults

Not recruiting

3 1 1 1
Investigated Drugs:
- Zoledronic Acid Monohydrate
Study on the Effectiveness and Safety of Mitapivat for Children with Pyruvate Kinase Deficiency Receiving Regular Blood Transfusions

Not recruiting

3 1
Investigated Drugs:
- Mitapivat
Study of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed

Not recruiting

2 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
- Bispecific Protein With A High-Affinity T-Cell Receptor Domain Fused To An Antibody Single-Chain Variable Fragment Against Cd3
Study of Ceralasertib for Patients with Advanced Cancer with Molecular Changes

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Ceralasertib
Study of PM14 and Irinotecan for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Ecubectedin
- Irinotecan
Study on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis

Not recruiting

3 1 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Mometasone Furoate Ph. Eur.
- Mometasone Furoate
Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Nivolumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies